Every 10-Q that Eve Holding, Inc. (EVEX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow EVEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EVEX filings page.
Eve Holding, Inc. reported Q2 2026 results as a pre‑revenue urban air mobility developer, narrowing its net loss while relying more on debt financing. For the quarter, net loss was 34,229 (in thousands), improving from 64,685, as research and development spending fell to 28,930 from 45,672. Selling, general and administrative costs were broadly flat, and a gain from warrant remeasurement and higher investment income offset increased interest expense.
At June 30, 2026, cash and cash equivalents were 52,210 (in thousands), with financial investments of 342,481 and restricted cash of 8,592, providing substantial liquidity alongside significant cash burn of 115,330 used in operating activities in the first half. Term loans outstanding rose to 313,093 (in thousands), including a new 150 million syndicated credit facility and additional BNDES‑backed borrowings, lifting total debt, net to 308,879. Equity declined to 22,831 (in thousands) as accumulated deficit widened to 810,131. The company continues to target commercialization of its eVTOL aircraft and related services from 2028 and states it will require substantial additional capital, expecting to fund operations through cash on hand, available credit lines, and capital markets transactions.
Eve Holding, Inc. reported a larger net loss of $68.8 million for the three months ended March 31, 2026, compared with $48.8 million a year earlier, as it remains in a pre-revenue development phase.
Research and development spending rose to $59.1 million, reflecting intensified eVTOL engineering, testing and industrialization efforts, while selling, general and administrative costs edged down to $7.2 million. The company ended the quarter with $129.4 million in cash, cash equivalents and restricted cash, $311.6 million in financial investments, and $303.6 million in term loans outstanding.
Management cites total available liquidity of about $578 million, including undrawn debt facilities and remaining grant commitments, which it believes is sufficient to fund operations for at least the next twelve months as Eve advances toward planned eVTOL commercialization.
Eve Holding, Inc. (EVEX) filed its Q3 2025 report showing deeper investment in development and a stronger balance sheet after new equity financing. Total assets rose to $439,676 (in thousands) from $318,242 at year-end, driven by $344,229 in held-to-maturity financial investments and $65,845 in cash and cash equivalents.
The company remains pre-revenue and reported a Q3 net loss of $46,866 (in thousands), as R&D expenses increased to $44,873 and SG&A was $7,025. For the nine months, net loss was $160,336. Financing activity was significant: in August–September, Eve completed a registered direct offering of approximately 47.4 million shares at $4.85 for gross proceeds of $230.0 million, including an investment by Embraer. As of November 4, 2025, there were 348,304,584 shares outstanding.
Debt, largely tied to Brazilian development lines and a Citibank facility, stood at $167,291 (long‑term, net). The company ended the period with $67,426 in cash, cash equivalents and restricted cash, after nine‑month operating cash outflows of $134,498, reflecting ongoing certification, engineering, and industrialization efforts for its eVTOL program and related service and UATM initiatives.